» Articles » PMID: 31383729

Δ-Tetrahydrocannabinol Suppresses Monocyte-Mediated Astrocyte Production of Monocyte Chemoattractant Protein 1 and Interleukin-6 in a Toll-Like Receptor 7-Stimulated Human Coculture

Overview
Specialty Pharmacology
Date 2019 Aug 7
PMID 31383729
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Cannabis is widely used in the United States, with an estimated prevalence of 9.5%. Certain cannabinoids in , Δ-tetrahydrocannabinol (THC) in particular, possess immune-modulating and anti-inflammatory activity. Depending on the context, the anti-inflammatory activity of cannabinoids may be beneficial (e.g., in treating inflammatory diseases) or detrimental to normal immune defense against pathogens. The potential beneficial effect of cannabinoids on chronic neuroinflammation has gained recent attention. Monocyte migration to the brain has been implicated as a key event in chronic neuroinflammation and in the etiology of central nervous system diseases including viral infection (e.g., human immunodeficiency virus-associated neurocognitive disorder). In the brain, monocytes can contribute to neuroinflammation through interactions with astrocytes, including inducing astrocyte secretion of cytokines and chemokines. In a human coculture system, monocyte-derived interleukin (IL)-1 due to Toll-like receptor 7 (TLR7) activation has been identified to promote astrocyte production of monocyte chemoattractant protein (MCP)-1 and IL-6. THC treatment of the TLR7-stimulated coculture suppressed monocyte secretion of IL-1, resulting in decreased astrocyte production of MCP-1 and IL-6. Furthermore, THC displayed direct inhibition of monocytes, as TLR7-stimulated monocyte monocultures treated with THC also showed suppressed IL-1 production. The cannabinoid receptor 2 (CB2) agonist, JWH-015, impaired monocyte IL-1 production similar to that of THC, suggesting that THC acts, in part, through CB2. THC also suppressed key elements of the IL-1 production pathway, including mRNA levels and caspase-1 activity. Collectively, this study demonstrates that the anti-inflammatory properties of THC suppress TLR7-induced monocyte secretion of IL-1 through CB2, which results in decreased astrocyte secretion of MCP-1 and IL-6. SIGNIFICANCE STATEMENT: Because cannabis use is highly prevalent in the United States and has putative anti-inflammatory properties, it is important to investigate the effect of cannabinoids on immune cell function. Furthermore, cannabinoids have garnered particular interest due to their potential beneficial effects on attenuating viral-induced chronic neuroinflammation. This study utilized a primary human coculture system to demonstrate that the major psychotropic cannabinoid in cannabis, Δ-tetrahydrocannabinol, and a cannabinoid receptor-2 selective agonist suppress specific monocyte-mediated astrocyte inflammatory responses.

Citing Articles

Timing matters: modeling the effects of gestational cannabis exposure on social behavior and microglia in the developing amygdala.

Pham A, Marquardt A, Montgomery K, Sobota K, McCarthy M, VanRyzin J bioRxiv. 2025; .

PMID: 40027715 PMC: 11870496. DOI: 10.1101/2025.02.17.638714.


Cannabis Use and Cannabidiol Modulate HIV-Induced Alterations in TREM2 Expression: Implications for Age-Related Neuropathogenesis.

Avalos B, Kulbe J, Ford M, Laird A, Walter K, Mante M Viruses. 2024; 16(10.

PMID: 39459844 PMC: 11512329. DOI: 10.3390/v16101509.


The Effects of Nicotine and Cannabinoids on Cytokines.

Miller G, Pareek O, Penman S, Thanos P Curr Pharm Des. 2024; 30(31):2468-2484.

PMID: 38859790 DOI: 10.2174/0113816128293077240529111824.


Exploring the versatile roles of the endocannabinoid system and phytocannabinoids in modulating bacterial infections.

Barker H, Ferraro M Infect Immun. 2024; 92(6):e0002024.

PMID: 38775488 PMC: 11237442. DOI: 10.1128/iai.00020-24.


Effects of Oral Cannabinoids on Systemic Inflammation and Viral Reservoir Markers in People with HIV on Antiretroviral Therapy: Results of the CTN PT028 Pilot Clinical Trial.

Mboumba Bouassa R, Comeau E, Alexandrova Y, Pagliuzza A, Yero A, Samarani S Cells. 2023; 12(14).

PMID: 37508476 PMC: 10378564. DOI: 10.3390/cells12141811.


References
1.
Sofroniew M, Vinters H . Astrocytes: biology and pathology. Acta Neuropathol. 2009; 119(1):7-35. PMC: 2799634. DOI: 10.1007/s00401-009-0619-8. View

2.
Karmaus P, Chen W, Kaplan B, Kaminski N . Δ9-tetrahydrocannabinol suppresses cytotoxic T lymphocyte function independent of CB1 and CB 2, disrupting early activation events. J Neuroimmune Pharmacol. 2011; 7(4):843-55. PMC: 3266990. DOI: 10.1007/s11481-011-9293-4. View

3.
Shao B, Wei W, Ke P, Xu Z, Zhou J, Liu C . Activating cannabinoid receptor 2 alleviates pathogenesis of experimental autoimmune encephalomyelitis via activation of autophagy and inhibiting NLRP3 inflammasome. CNS Neurosci Ther. 2014; 20(12):1021-8. PMC: 6492996. DOI: 10.1111/cns.12349. View

4.
Katchan V, David P, Shoenfeld Y . Cannabinoids and autoimmune diseases: A systematic review. Autoimmun Rev. 2016; 15(6):513-28. DOI: 10.1016/j.autrev.2016.02.008. View

5.
Zhu W, Friedman H, Klein T . Delta9-tetrahydrocannabinol induces apoptosis in macrophages and lymphocytes: involvement of Bcl-2 and caspase-1. J Pharmacol Exp Ther. 1998; 286(2):1103-9. View